This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Innovations of Chundru Balasubramanyam
Introduction
Chundru Balasubramanyam is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit Ca/calmodulin-dependent protein kinase (CaMKII). With a total of 2 patents, his work has implications for various therapeutic applications.
Latest Patents
Balasubramanyam's latest patents focus on CaMKII inhibitors and their uses. The present invention provides compounds that are useful as inhibitors of CaMKII, along with compositions and methods for utilizing these compounds effectively. This innovation holds promise for advancing treatments in related medical fields.
Career Highlights
Chundru Balasubramanyam is affiliated with The Johns Hopkins University, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on understanding and treating diseases linked to CaMKII activity.
Collaborations
Some of his notable coworkers include Daniel Emil Levy and Howard Schulman. Their collaborative efforts contribute to the advancement of research in their respective fields.
Conclusion
Chundru Balasubramanyam's contributions to the field of biochemistry through his innovative patents highlight his role as a significant inventor. His work on CaMKII inhibitors showcases the potential for new therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile